Aeterna Zentaris
AEZS
#10801
Rank
C$24.75 M
Marketcap
C$8.08
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2023 (TTM): C-$6.32

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is C-$2.90. In 2022 the company made an earnings per share (EPS) of C-$6.60 a decrease over its 2021 EPS that were of C-$2.77.

EPS history for Aeterna Zentaris from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$6.32-4.3%
2022C-$6.60138.27%
2021C-$2.77-48.05%
2020C-$5.33-56.88%
2019C-$12.37-240%
2018C$8.83-122.94%
2017C-$38.52-54.96%
2016C-$85.51-93.07%
2015C-$1,23420.13%
2014C-$1,027-225.69%
2013C$816.96-122.24%
2012C-$3,674-42.55%
2011C-$6,396-12.98%
2010C-$7,350-17.46%
2009C-$8,905-62.5%
2008C-$23,74583.66%
2007C-$12,929-227.16%
2006C$10,168105.81%
2005C$4,940-334.56%
2004C-$2,106-79.94%
2003C-$10,50113.5%
2002C-$9,252604.55%
2001C-$1,313-84.33%
2000C-$8,382275.3%
1999C-$2,233

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.42-356.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$2.69-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$6.39-320.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.51-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
C$4.98-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA